Antibiotic | Susceptible (S), N (%) | Intermediate (I), N (%) | Resistant (R), N (%) | Interpretive categories and zone diameter breakpoints (mm) | ||
---|---|---|---|---|---|---|
S | I | R | ||||
Imipenem | 0 (0.0) | 0 (0.0) | 106 (100) | ≥ 22 | 19–21 | ≤ 18 |
Ceftazidime | 0 (0.0) | 0 (0.0) | 106 (100) | ≥ 18 | 15–17 | ≤ 14 |
Gentamicin | 5 (4.7) | 2 (1.9) | 99 (93.4) | ≥ 15 | 13–14 | ≤ 12 |
Doxycycline | 101 (95.3) | 0 (0.0) | 5 (4.7) | ≥ 13 | 10–12 | ≤ 9 |
Minocycline | 102 (96.2) | 4 (3.8) | 0 (0.0) | ≥ 16 | 13–15 | ≤ 12 |
Ciprofloxacin | 5 (4.7) | 0 (0.0) | 101 (95.3) | ≥ 21 | 16–20 | ≤ 15 |
Ampicillin-sulbactam | 100 (94.3) | 0 (0.0) | 6 (5.7) | ≥ 15 | 12–14 | ≤ 11 |
Trimethoprim/sulfamethaxazole | 0 (0.0) | 0 (0.0) | 106 (100) | ≥ 16 | 11–15 | ≤ 10 |